Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

then Rubinfeld must have also know that AMBS didn't have the financing to fund the ESS test trials either, or bring it to market, which meant that the shareholders were going to be diluted once again. Yet Gerald continued to pontificate that the USDOD believed ESS was too important to let fail - and if that were the case, then where's the US AFIRM financing? It was precisely 17 months ago that AMBS secured ESS and we still have no grant financing from the UA ARMY. Why not if it was so great? This is why I say these guys have turned AMBS into a total crap shoot, in order to make anything stick to the wall here in 'hopes' that something will bring value. This business plan of theirs is absolute insanity and will now require yet another RA and AS increase.

They were 100% correct for using the below Business Plan model. It fits AMBS's mantra of 'lets make it up as we go along and hype the company in efforts to entice shareholders'.

Rubinfeld was quoted at the Sept., 2014, ASM as stating "were there" regarding LymPro's launch and commercialization. Yet LymPro hasn't even achieved CLIA, let alone AMBS's 'marketing plan' and Gerald stated they were in process of almost 2 years ago. What happened to the marketing plan?

Shame on management and the BOD. IMHO, they're all despicable. In the private sector, they would all have been fired long ago:

Preparing Amarantus for the Up-list in 2H-14: Capital Markets Strategy
Posted on August 10th, 2014

http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/preparing-amarantus-list-2h-14-capital-markets-strategy/



AJMHO